Benzylamine

Identification

Generic Name
Benzylamine
DrugBank Accession Number
DB02464
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 107.1531
Monoisotopic: 107.073499293
Chemical Formula
C7H9N
Synonyms
Not Available

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UTrypsin-2Not AvailableHumans
UTrypsin-1Not AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
75% Alcohol WipesBenzylamine (0.1 mg/100mL) + Ethanol (75 mL/100mL) + Methylisothiazolinone (0.1 mg/100mL)ClothTopicalZhejiang Lake Products Co.,Ltd2020-06-09Not applicableUS flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenylmethylamines. These are compounds containing a phenylmethtylamine moiety, which consists of a phenyl group substituted by an methanamine.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Phenylmethylamines
Direct Parent
Phenylmethylamines
Alternative Parents
Benzylamines / Aralkylamines / Organopnictogen compounds / Monoalkylamines / Hydrocarbon derivatives
Substituents
Amine / Aralkylamine / Aromatic homomonocyclic compound / Benzylamine / Hydrocarbon derivative / Organic nitrogen compound / Organonitrogen compound / Organopnictogen compound / Phenylmethylamine / Primary aliphatic amine
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
aralkylamine, primary amine (CHEBI:40538)
Affected organisms
Not Available

Chemical Identifiers

UNII
A1O31ROR09
CAS number
100-46-9
InChI Key
WGQKYBSKWIADBV-UHFFFAOYSA-N
InChI
InChI=1S/C7H9N/c8-6-7-4-2-1-3-5-7/h1-5H,6,8H2
IUPAC Name
phenylmethanamine
SMILES
NCC1=CC=CC=C1

References

Synthesis Reference

Richard A. Plunkett, Jerry L. Neff, Timothy A. Bemish, "Process for the production of benzylamine and dibenzylamine." U.S. Patent US4163025, issued May, 1971.

US4163025
General References
Not Available
Human Metabolome Database
HMDB0033871
KEGG Compound
C15562
PubChem Compound
7504
PubChem Substance
46507683
ChemSpider
7223
BindingDB
10999
ChEBI
40538
ChEMBL
CHEMBL522
ZINC
ZINC000006096244
PDBe Ligand
ABN
Wikipedia
Benzylamine
PDB Entries
1n6x / 1n6y / 1utj / 1utn / 2bza / 2eus / 2hxc / 3nzj / 3nzw / 3nzx
show 9 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
ClothTopical
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)10 °CPhysProp
boiling point (°C)185 °CPhysProp
water solubility1E+006 mg/L (at 20 °C)YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP1.09HANSCH,C ET AL. (1995)
pKa9.33 (at 25 °C)WEAST,RC (1985)
Predicted Properties
PropertyValueSource
Water Solubility9.71 mg/mLALOGPS
logP0.9ALOGPS
logP1.1ChemAxon
logS-1ALOGPS
pKa (Strongest Basic)9.51ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area26.02 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity34.53 m3·mol-1ChemAxon
Polarizability12.32 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9926
Blood Brain Barrier+0.9382
Caco-2 permeable+0.8407
P-glycoprotein substrateNon-substrate0.8225
P-glycoprotein inhibitor INon-inhibitor0.9845
P-glycoprotein inhibitor IINon-inhibitor0.9601
Renal organic cation transporterNon-inhibitor0.6882
CYP450 2C9 substrateNon-substrate0.8819
CYP450 2D6 substrateNon-substrate0.6766
CYP450 3A4 substrateNon-substrate0.8479
CYP450 1A2 substrateInhibitor0.8224
CYP450 2C9 inhibitorInhibitor0.5721
CYP450 2D6 inhibitorNon-inhibitor0.8321
CYP450 2C19 inhibitorNon-inhibitor0.7125
CYP450 3A4 inhibitorNon-inhibitor0.8658
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.679
Ames testNon AMES toxic0.9473
CarcinogenicityNon-carcinogens0.5871
BiodegradationReady biodegradable0.6776
Rat acute toxicity2.3096 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8813
hERG inhibition (predictor II)Non-inhibitor0.8996
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (2 TMS)GC-MSsplash10-01p9-4920000000-0f4ada396b9bee541485
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - EI-BGC-MSsplash10-0a6r-9600000000-76805d0c1bcba470e1e9
GC-MS Spectrum - EI-BGC-MSsplash10-0a6r-9500000000-3b232f493a2c14360f5f
GC-MS Spectrum - EI-BGC-MSsplash10-0a6r-9700000000-7e253eff483b8a31ec7a
GC-MS Spectrum - GC-MSGC-MSsplash10-01p9-4920000000-0f4ada396b9bee541485
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-000i-3920000000-24949e7f9e479e44f96a
Mass Spectrum (Electron Ionization)MSsplash10-0a4i-8900000000-7ef28c10b30a125e9a04
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-0900000000-2ea49c7261b19840449d
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-1900000000-4c1b78093f6f02248c71
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-1029-9100000000-ae7d6de0223ba67982ac
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-1900000000-aabc088d9596196c825a
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-3900000000-9f49843e6a51d164a115
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9100000000-bc7bd1bfabbb6f8aff5b
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-79ff95be504a5efad264
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-79ff95be504a5efad264
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-79ff95be504a5efad264
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-864a48552fea562fc370
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-79ff95be504a5efad264
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-8427480b81d41b80571e
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-10b0a2c3d32b9a216fb0
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-eae6015976352ec30df3
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-f5b6e01ed535982c3a2f
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-546d86dcbfb4752d0739
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-f81d8a7234ccf1e8d6b7
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-f49cbaea9ee4d92d9d2d
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-1180a5ab497a1bedf753
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-00kf-9000000000-df34f470ef53726c9f4c
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-0a4i-0900000000-de01e2fbc1afc209a498
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable

Targets

Drugtargets2
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Serine-type endopeptidase activity
Specific Function
In the ileum, may be involved in defensin processing, including DEFA5.
Gene Name
PRSS2
Uniprot ID
P07478
Uniprot Name
Trypsin-2
Molecular Weight
26487.55 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Details
2. Trypsin-1
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Serine-type endopeptidase activity
Specific Function
Has activity against the synthetic substrates Boc-Phe-Ser-Arg-Mec, Boc-Leu-Thr-Arg-Mec, Boc-Gln-Ala-Arg-Mec and Boc-Val-Pro-Arg-Mec. The single-chain form is more active than the two-chain form aga...
Gene Name
PRSS1
Uniprot ID
P07477
Uniprot Name
Trypsin-1
Molecular Weight
26557.88 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created on June 13, 2005 13:24 / Updated on July 02, 2020 13:17